Skip to main content

Advertisement

Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates

Table 1 Summary of the pathological classification of glioma in index patients

From: Downregulation of CDKN2A and suppression of cyclin D1 gene expressions in malignant gliomas

Glioma classification WHO grade Male/Female N Age(years)
Pilocytic Astrocytoma(PA) I 3/1 4 27.1 ± 10.3
Astrocytoma(A) II 11/5 16 47.2 ± 6.9
Oligodendroglioma(O) II 3/3 6 54.8 ± 9.2
Low-Grade glioma   17/9 26 48.3 ± 9.1
Anaplastic Astrocytoma(AA) III 6/3 9 44.2 ± 10.7
Anaplastic Oligodendroglioma(AO) III 4/1 5 47.9 ± 5.4
Glioblastoma Multiforme(GBM) IV 16/5 21 55.3 ± 9.5
High-Grade glioma   26/9 35 52.2 ± 9.8